CSI Market
Sign In | Register

Maravai Lifesciences Holdings Inc (MRVI) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access MRVI Annual Cash Flow →
This cash flow overview for Maravai Lifesciences Holdings Inc spans from Jun 30 2025 to Jun 30 2026, illustrating how cash generation and usage have shifted across recent reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-44.16
Depreciation & amortization10.21
Amortization of Other Assets12.94
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges3.55
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.74
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business0.00
Share-based Compensation16.95
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt-3.41
Interest Expense Lessee Assets Under Capital Lease-
Gain Loss On Tax Receivable Agreement-
Depreciation Including Adjustments-
Operating Lease Right Of Use Asset Amortization Expense1.61
Capital Expenditures Incurred But Not Yet Paid0.25
Sale And Leaseback Transaction Gain Loss Net-
Increase Decrease In Government Funding Receivable-
Conversion Of Stock Amount Converted For Blocker Mergers-
Conversion Of Stock Deferred Tax Asset-
Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed-
Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction-
Business Combination Contingent Consideration Change In Contingent Consideration Liability Increase Decrease Noncash-
Increase Decrease In Contract With Customer Liability-
Income taxes0.00
Unrealized Gain (Loss) on Derivatives0.00
Increase (Decrease) in Accounts Receivable5.63
Increase (Decrease) in Accounts Payable4.36
Increase (Decrease) in Accrued Liabilities-3.52
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.66
Other Working Capital-1.89
Other Noncash Income (Expense)-0.20
Other net-11.86
Payments for (Proceeds from) Other Operating Activities26.76
Discontinued operations-2.76
Net Cash flow from Operating Activities12.66
Investing Activities
Capital Expenditures-4.81
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Government Assistance Allocated To Property And Equipment-
Finance Lease Prepayments Lease Not Yet Commenced-
Payments For Acquisition Deposit-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses, Net of Cash Divested0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-4.81
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-3.58
Long-term debt - borrowings150.00
Long-term debt - repayments-294.24
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-0.46
Other net-5.94
Finance Lease Principal Payments-
Payments For Tax Receivable Agreement-
Payments To Acquire Limited Liability Company Units-
Payment Of Acquisition Contingent Consideration Holdback-
Tax Withholding Obligation Net Of Proceeds-
Share Based Payment Arrangement Value Shares Withheld For Tax Withholding Obligation-
Payments For Proceeds From Tax Liabilities With Non Controlling Interests-
Payments of Ordinary Dividends, Noncontrolling Interest0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-154.21
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow7.85
Total Cash Flow-146.31
4 historic quarters locked

Sign in to unlock the full Maravai Lifesciences Holdings Inc cash flow history.

Sign In Create Free Account

About Maravai Lifesciences Holdings Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001823239-26-000059

Figures are derived from filed reports and may be restated. Historical data is subject to revision.